**Chapter 4**

*Current Cancer Treatment*

2013;**342**(6161):967-970

2018;**359**(6371):91-97

[189] Iida N et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science.

[190] Matson V et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;**359**(6371):104-108

[191] Routy B et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (New York, N.Y.).

[192] Taur Y et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

Blood. 2014;**124**(7):1174-1182

[194] Routy B et al. The gut microbiota influences anticancer

2018;**15**(6):382-396

[193] Viaud S et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;**342**(6161):971-976

immunosurveillance and general health. Nature Reviews. Clinical Oncology.

**100**
